At a glance
Published papers
Abimbola TO, Van Handel M, Marks SM, Beeler Asay GR, Sandul A, Gift TL, Durham MD, Pampati S, Salomon JA, Martin EG, Mermin J. A decade of the National Center for HIV, Viral Hepatitis, STD, and TB Prevention's Epidemiologic and Economic Modeling Agreement. Public Health Rep. 2026;141(2):167-180. doi:10.1177/00333549251384457
Cilloni, L., Docrat, R., Haring, C., Marks, S. M., Dowdy, D., & Shrestha, S. (2026). Impact of the COVID-19 pandemic on tuberculosis epidemiology in California, Florida, New York, and Texas. Annals of the American Thoracic Society, 23(4), 516-526.
Regan M, Cui H, Swartwood NA, Li Y, Marks SM, Barham T, Khan A, Winston CA, Cohen T, Horsburgh CR, Salomon JA, Menzies NA. The potential effect of a geographically focused intervention against tuberculosis in the USA: A simulation modelling study. Lancet Public Health. 2026;11(2):e82-e91.
Swartwood NA, Cohen T, Marks SM, Hill AN, Beeler Asay GR, Feng PJI, Horsburgh CR, Salomon JA, Menzies NA. Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis. Clinical Infectious Diseases. 2026;81(6):e659-e667.
Shrestha, S., Cilloni, L., Asay, G., Kammerer, J., Raz, K., Shaw, T....Dowdy, D. (2025). Model-Based Analysis of Impact, Costs, and Cost-effectiveness of Tuberculosis Outbreak Investigations, United States. Emerging Infectious Diseases, 31(3), 497-506.
Li Y, Marks SM, Beeler Asay GR, Winston CA, Pepin D, McClure S, Swartwood NA, Cohen T, Horsburgh CR, Salomon JA, Menzies NA. Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022. Ann Intern Med. 2025;178(4):479-489.
Menzies NA, Marks SM, Hsieh YL, Swartwood NA, Beeler Asay GR, Skarbinski J, Horsburgh CR, Cohen T. Contribution of Post-TB Sequelae to Life-Years Lost from TB Disease in the United States, 2015-2019. Am J Respir Crit Care Med. 2025;211(6):1059-1068.
Swartwood NA, Haddad MB, Marks SM, Beeler Asay GR, Horsburgh CR, Cohen T, Menzies NA. Health impact and cost-effectiveness of testing and treatment of Mycobacterium tuberculosis infection among Asian and Hispanic persons with diagnosed diabetes in the United States. Value Health. 2025;28(7):1029-1037.
Swartwood NA, Li Y, Regan M, Marks SM, Barham T, Beeler Asay GR, Cohen T, Hill AN, Horsburgh CR, Khan AD, Hubbard McCree D, Myles RL, Salomon JA, Self JL, Menzies NA. Estimated Health and Economic Outcomes of Racial and Ethnic Tuberculosis Disparities in US-Born Persons. JAMA Netw Open. 2024;7(9):e2431988.
Menzies NA, Swartwood NA, Cohen T, Marks SM, Maloney SA, Chappelle C, Miller JW, Beeler Asay GR, Date AA, Horsburgh CR, Salomon JA. The long-term effects of domestic and international tuberculosis service improvements on tuberculosis trends within the USA: a mathematical modelling study. Lancet Public Health. 2024;9(8):e573-e582.
Regan M, Barham T, Li Y, Swartwood N, Beeler Asay G, Cohen T, Horsburgh CR, Khan A, Marks SM,, Myles R, Salomon JA, Self J, Winston C, Menzies NA. Risk factors underlying racial and ethnic disparities in tuberculosis diagnosis and treatment outcomes, 2011-19: a multiple mediation analysis of national surveillance data. Lancet Public Health. 2024;9(8):e564-e572.
Regan M, Li Y, Swartwood N, Barham T, Beeler Asay GR, Cohen T, Hill AN, Horsburgh CR, Khan A, Marks SM, Myles RL, Salomon JA, Self JL, Menzies NA. Racial and ethnic disparities in diagnosis and treatment outcomes among US-born people diagnosed with tuberculosis, 2003–19: An analysis of national surveillance data. Lancet Public Health. 2024;9(1):e47-e56. doi:10.1016/S2468-2667(23)00276-1
Ekramnia M, Li Y, Haddad MB, Marks SM, Kammerer JS, Swartwood NA, Cohen T, Miller JW, Horsburgh CR, Salomon JA, Menzies NA. Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States. Epidemiology. 2024;35(2):164-173. doi:10.1097/EDE.0000000000001707
Li Y, Regan M, Swartwood NA, Barham T, Beeler Asay GR, Cohen T, Hill AN, Horsburgh CR, Khan A, Marks SM, Myles RL, Salomon JA, Self JL, Menzies NA. Disparities in tuberculosis incidence by race and ethnicity among the U.S.-born population in the United States, 2011 to 2021: An analysis of national disease registry data. Ann Intern Med. 2024;177(4):418-427. doi:10.7326/M23-2975
Swartwood NA, Testa C, Cohen T, Marks SM, Hill AN, Asay GB, Cochran J, Cranston K, Randall LM, Tibbs A, Horsburgh CR, Salomon JA, Menzies NA. Tabby2: A user-friendly web tool for forecasting state-level TB outcomes in the United States. BMC Med. 2023;21:331. doi:10.1186/s12916-023-02785-y
Kim S, Cohen T, Horsburgh CR, et al. Trends, Mechanisms, and Racial/Ethnic Differences of Tuberculosis Incidence in the US-Born Population Aged 50 Years or Older in the United States.Clin Infect Dis. 2022;74(9):1594-1603. doi:10.1093/cid/ciab668
Raz KM, Talarico S, Althomsons SP, Kammerer JS, Cowan LS, Haddad MB, McDaniel CJ, Wortham JM, France AM, Powell KM, Posey JE, Silk BJ. Molecular surveillance for large outbreaks of tuberculosis in the United States, 2014-2018. Tuberculosis (Edinb). 2022 Aug 9;136:102232.
Shrestha, S., Winglee, K., Hill, A., Shaw, T., Smith, J., Kammerer, J. S., Silk, B. J., Marks, S., & Dowdy, D. (2022). Model-based analysis of tuberculosis genotype clusters in the United States reveals high degree of heterogeneity in transmission, and state-level differences across California, Florida, New York, and Texas. Clinical Infectious Diseases.
Smith JP, Gandhi NR, Silk BJ, Cohen T, Lopman B, Raz K, Winglee K, Kammerer S, Benkeser D, Kramer MR, Hill AN. A Cluster-based Method to Quantify Individual Heterogeneity in Tuberculosis Transmission. Epidemiology. 2022 Mar 1;33(2):217-227.
Menzies, Nicolas A.a; Shrestha, Souryab; Parriott, Andreac; Marks, Suzanne M.d; Hill, Andrew N.d; Dowdy, David W.b; Shete, Priya B.e; Cohen, Tedf; Salomon, Joshua A.g. The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease. Epidemiology: January 2022 – Volume 33 – Issue 1 – p 75-83.
Mirzazadeh A, Fellow IE, Ashki H, Parriott A, Readhead A, Barry P, Flood J, Navin TR, Hill AN, Reynolds S, Marks S, McCabe D, Mermin J, Kahn JG, Shete PB. Estimating Latent Tuberculosis Infection Prevalence in the United States: Back-Calculation from Active TB Cases. PLOS ONE. In press 2021.
Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, Cohen T, Salomon JA. Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States. Epidemiology. 2021 Jan;32(1):70-78.
Hill AN, Cohen T, Salomon JA, Menzies NA. High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000-2016. Epidemics. 2020 Dec;33:100419.
Shrestha S, Parriott A, Menzies NA, Shete PB, Hill AN, Marks SM, Dowdy DW. Estimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States. Annals of the American Thoracic Society. 2020 Dec;17(12):1639-1642.
Menzies NA, Bellerose M, Testa C, Swartwood N, Malyuta Y, Cohen T, Marks SM, Hill AN, Date A, Maloney SA, Bowden S, Grills A, Salomon JA. Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States. American Journal of Respiratory and Critical Care Medicine. 2020 Dec 1;202(11):1567-1575.
Marks SM, Dowdy DW, Menzies NA, Shete PB, Salomon JA, Parriott A, Shete PB, Shrestha S, Dowdy DW, Flood J, Hill AN. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate TB Elimination. Public Health Reports. 2020;135(1:supplement).
Parriott A, Shete PB, Readhead A, Barry PM, Flood J, Kahn JG. Modelling the Impact of Recommendations for Primary Care-Based Screening for Latent Tuberculosis Infection in California. Public Health Reports. 2020;135(1:supplement).
Jo Y, Shrestha S, Gomes I, Marks S, Hill A, Asay G, and Dowdy D. Model-Based Cost-Effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York and Texas. Clin Infect Dis. doi:10.1093/cid/ciaa857 June 2020. PMCID: PMC807772
Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay G, Barry P. Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California. American Journal of Respiratory and Critical Care Medicine. 2019 Oct 18(ja).
Miller AP, Malekinejad M, Horváth H, Blodgett JC, Kahn JG, Marks SM. Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-US-born population in the United States: A systematic review. PloS One. 2019;14(9).
Shrestha S, Cherng S, Hill AN, Reynolds S, Flood J, Barry PM, Readhead A, Oxtoby M, Lauzardo M, Privett T, Marks SM. Impact and Effectiveness of State-level Tuberculosis Interventions in California, Florida, New York and Texas: A Model-based Analysis. American journal of epidemiology. 2019 Jun 28.
Goodell AJ, Shete PB, Vreman R, McCabe D, Porco TC, Barry PM, Flood J, Marks SM, Hill A, Cattamanchi A, Kahn JG. Outlook for Tuberculosis Elimination in California: An Individual-based Stochastic Model. PloS one. 2019 Apr 9;14(4):e0214532.
Menzies NA, Hill AN, Cohen T, Salomon JA. The impact of migration on tuberculosis in the United States. The International Journal of Tuberculosis and Lung Disease. 2018 Dec 1;22(12):1392-403.
Cherng, S. T., Shrestha, S., Reynolds, S., Hill, A. N., Marks, S. M., Kelly, J., Dowdy, D. W. Tuberculosis Incidence Among Populations at High Risk in California, Florida, New York, and Texas, 2011–2015, American Journal of Public Health 2018 Nov;108(S4):S311-4. Accessed 11/7/2018.
Parriott A, Malekinejad M, Miller AP, Horvath H, Marks SM, Kahn JG. Yield of Testing and Treatment for Tuberculosis Among Foreign-Born Persons During Contact Investigations in the United States: A Semi-Systematic Review. PLoS ONE. 2018 Jul 19;13(7):e0200485.
Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, Marks SM, Salomon JA. Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model. American Journal of Epidemiology. 2018 May 14;187(9):2011-20.
Parriott A, Malekinejad M, Miller AP, Marks SM, Horvath H, Kahn JG. Care Cascade for Targeted Tuberculosis Testing and Linkage to Care in Homeless Populations in the United States: a Meta-Analysis. BMC Public Health. 2018 Apr 12;18(1):485. Accessed 5/18/2018.
Menzies NA, Wolf E, Connors D, Bellerose M, Sbarra AN, Cohen T, Hill AN, Yaesoubi R, Galer K, White PJ, Abubakar I, Salomon JA. Progression from Latent Infection to Active Disease in Dynamic Tuberculosis Transmission Models: a Systematic Review of the Validity of Modelling Assumptions. The Lancet Infectious Diseases. 2018 Apr 10. Accessed 5/18/2018.
Tasillo A, Salomon JA, Trikalinos TA, Horsburgh CR, Marks SM, Linas BP. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model. JAMA Internal Medicine. 2017 Dec 1;177(12):1755-1764. Accessed 2/9/2018.
Malekinejad M, Parriott A, Viitanen AP, Horvath H, Marks SM, Kahn JG. Yield of Community-Based Tuberculosis Targeted Testing and Treatment in Foreign-Born Populations in the United States: A Systematic Review. PloS one. 2017 Aug 7;12(8):e0180707.
Shrestha S, Hill AN, Marks SM, Dowdy DW. Comparing Drivers and Dynamics of Tuberculosis (TB) in California, Florida, New York and Texas. American Journal of Respiratory And Critical Care Medicine. 2017 May 5(ja). Accessed 6/9/2017.